Zymeworks(ZYME)
$29.07-2.39 (-7.60%)
ZYME
Zymeworks financials statements
$29.07
At close:-2.39 (-7.60%)
Want to see ZYME full AI Analyst Report?
Zymeworks (ZYME) Ratios
670 Followers
Zymeworks Ratios
ZYME's free cash flow for Q3 2026 was $-24.11M. For the 2026 fiscal year, ZYME's free cash flow was decreased by $-73.00K and operating cash flow was $-24.04M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.52 | 3.40 | 7.41 | 5.70 | 4.01 |
| Quick Ratio | 5.52 | 3.40 | 7.41 | 5.70 | 4.01 |
| Cash Ratio | 0.97 | 0.75 | 2.83 | 4.19 | 2.81 |
| Solvency Ratio | -0.90 | -0.90 | -0.87 | 0.88 | -1.44 |
| Operating Cash Flow Ratio | -0.78 | -1.25 | -2.12 | 1.51 | -2.68 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 155.41M | $ 176.13M | $ 296.85M | $ 388.94M | $ 148.18M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.04 | 0.05 | 0.04 | 0.08 |
| Debt-to-Equity Ratio | 0.07 | 0.05 | 0.06 | 0.06 | 0.13 |
| Debt-to-Capital Ratio | 0.06 | 0.05 | 0.05 | 0.05 | 0.11 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.29 | 1.37 | 1.25 | 1.32 | 1.56 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.24 | 0.24 | 0.39 | 0.43 | 0.62 |
| Net Debt to EBITDA | 0.33 | 0.44 | 1.08 | -2.62 | 0.82 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 100.00% | -88.11% | 100.00% | 100.00% |
| EBIT Margin | -75.26% | -157.03% | -181.56% | 31.63% | -808.37% |
| EBITDA Margin | -64.78% | -142.36% | -158.79% | 34.54% | -772.45% |
| Operating Profit Margin | -87.33% | -179.69% | -181.62% | 31.64% | -808.22% |
| Pretax Profit Margin | -75.26% | -152.82% | -156.87% | 32.79% | -795.95% |
| Net Profit Margin | -76.56% | -160.80% | -156.13% | 30.14% | -794.01% |
| Continuous Operations Profit Margin | -76.56% | -160.80% | -156.13% | 30.14% | -794.01% |
| Net Income Per EBT | 101.73% | 105.22% | 99.52% | 91.95% | 99.76% |
| EBT Per EBIT | 86.19% | 85.05% | 86.37% | 103.61% | 98.48% |
| Return on Assets (ROA) | -23.41% | -26.49% | -20.43% | 19.17% | -54.44% |
| Return on Equity (ROE) | -30.22% | -36.22% | -25.53% | 25.22% | -85.05% |
| Return on Capital Employed (ROCE) | -30.42% | -36.58% | -26.29% | 23.60% | -67.96% |
| Return on Invested Capital (ROIC) | -30.08% | -36.32% | -25.95% | 21.57% | -67.52% |
| Return on Tangible Assets | 0.62% | -27.48% | -21.83% | 20.37% | -59.57% |
| Earnings Yield | -4.09% | -11.05% | -16.59% | 24.26% | -24.79% |
| Efficiency Ratios | |||||
| Receivables Turnover | 22.85 | 1.37 | 3.90 | 12.35 | 1.71 |
| Payables Turnover | 0.00 | 0.00 | 23.02 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 2.22 | 2.02 | 8.66 | 0.54 |
| Asset Turnover | 0.31 | 0.16 | 0.13 | 0.64 | 0.07 |
| Working Capital Turnover Ratio | 0.53 | 0.27 | 0.19 | 1.24 | 0.09 |
| Cash Conversion Cycle | 15.98 | 266.99 | 77.67 | 29.56 | 213.61 |
| Days of Sales Outstanding | 15.98 | 266.99 | 93.53 | 29.56 | 213.61 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 15.86 | 0.00 | 0.00 |
| Operating Cycle | 15.98 | 266.99 | 93.53 | 29.56 | 213.61 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.44 | -1.45 | -1.72 | 2.21 | -3.69 |
| Free Cash Flow Per Share | -0.46 | -1.49 | -1.78 | 2.01 | -3.95 |
| Dividend Paid and CapEx Coverage Ratio | -21.70 | -35.89 | -29.02 | 10.98 | -14.49 |
| Capital Expenditure Coverage Ratio | -21.70 | -35.89 | -29.02 | 10.98 | -14.49 |
| Operating Cash Flow Coverage Ratio | -1.81 | -5.95 | -4.43 | 5.13 | -5.95 |
| Operating Cash Flow to Sales Ratio | -0.31 | -1.44 | -1.56 | 0.35 | -7.21 |
| Free Cash Flow Yield | -1.74% | -10.19% | -17.10% | 25.56% | -24.08% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -24.38 | -9.04 | -6.03 | 4.12 | -4.03 |
| Price-to-Sales (P/S) Ratio | 18.72 | 14.55 | 9.41 | 1.24 | 32.03 |
| Price-to-Book (P/B) Ratio | 7.39 | 3.28 | 1.54 | 1.04 | 3.43 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -57.45 | -9.82 | -5.85 | 3.91 | -4.15 |
| Price-to-Operating Cash Flow Ratio | -60.10 | -10.09 | -6.05 | 3.56 | -4.44 |
| Price-to-Earnings Growth (PEG) Ratio | 0.73 | 1.55 | 0.03 | -0.03 | -0.30 |
| Enterprise Value Multiple | -28.56 | -9.78 | -4.84 | 0.98 | -3.32 |
| Enterprise Value | 1.96B | 1.06B | 584.65M | 139.63M | 684.90M |
| EV to EBITDA | -28.56 | -9.78 | -4.84 | 0.98 | -3.32 |
| EV to Sales | 18.50 | 13.93 | 7.69 | 0.34 | 25.67 |
| EV to Free Cash Flow | -56.79 | -9.40 | -4.78 | 1.07 | -3.33 |
| EV to Operating Cash Flow | -59.41 | -9.66 | -4.94 | 0.97 | -3.56 |
| Tangible Book Value Per Share | -173.85 | 4.25 | 6.21 | 6.97 | 4.14 |
| Shareholders’ Equity Per Share | 3.56 | 4.47 | 6.75 | 7.56 | 4.78 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.02 | -0.05 | 0.00 | 0.08 | 0.00 |
| Revenue Per Share | 1.41 | 1.01 | 1.10 | 6.33 | 0.51 |
| Net Income Per Share | -1.08 | -1.62 | -1.72 | 1.91 | -4.06 |
| Tax Burden | 1.02 | 1.05 | 1.00 | 0.92 | 1.00 |
| Interest Burden | 1.00 | 0.97 | 0.86 | 1.04 | 0.98 |
| Research & Development to Revenue | 1.29 | 1.76 | 1.89 | 0.51 | 7.49 |
| SG&A to Revenue | 0.58 | 0.81 | 0.93 | 0.18 | 1.60 |
| Stock-Based Compensation to Revenue | 0.26 | 0.23 | 0.11 | 0.01 | 0.40 |
| Income Quality | 0.41 | 0.90 | 1.00 | 1.16 | 0.91 |
Currency in USD
